Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM)

This study is currently recruiting participants.
Verified August 2012 by Heinrich-Heine University, Duesseldorf
Sponsor:
Collaborator:
German Federal Ministry of Education and Research
Information provided by (Responsible Party):
Wolfgang Gaebel, Professor, Heinrich-Heine University, Duesseldorf
ClinicalTrials.gov Identifier:
NCT01655368
First received: June 14, 2012
Last updated: August 2, 2012
Last verified: August 2012

June 14, 2012
August 2, 2012
May 2012
March 2014   (final data collection date for primary outcome measure)
subjective quality of life [ Time Frame: 12 months after intervention ] [ Designated as safety issue: No ]

subjective quality of life 12 months after intervention determined by WHOQOL-BREF total score.

To impart coping-strategies in handling stigmatization and to develop empowerment by embedding a psychotherapeutic module in psychoeducational groups.

Same as current
Complete list of historical versions of study NCT01655368 on ClinicalTrials.gov Archive Site
  • self-stigma (ISMI) [ Time Frame: after 6 weeks, 6 months, 12 months ] [ Designated as safety issue: No ]
  • empowerment (BUES) [ Time Frame: after 6 weeks, 6 months, 12 months ] [ Designated as safety issue: No ]
  • health care utilization (CSSRI, EQ5-D, SF-36) [ Time Frame: after 6 weeks, 6 months, 12 months ] [ Designated as safety issue: No ]
Same as current
 
 
 
Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM)
Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM)

This multi-center, 2-arm interventional study within different mental health care settings (psychiatry: in-patient, day-unit and out-patient, as well as psychiatric rehabilitation) evaluates a psychotherapeutic group intervention to improve stigma coping and empowerment using a psychotherapeutic module embedded in a psychoeducational group therapy.

People with mental illness suffer both from the burden of disease itself and from the social stigma related to mental illness, hence impeding their treatment (Sartorius et al. 2005, Link et al. 1999). Negative attitudes towards and discriminating behavior against people with mental illness negatively affect health care utilization, the course of disease, compliance, self-esteem, and social functioning (Sirey et al. 2001, Link et al. 2001, Perlick et al. 2001). Internalizing negative social stereotypes (self-stigmatization; Ritsher et al. 2003, Watson et al. 2007) impairs the quality of life and leads to social withdrawal (Rüesch 2005). Furthermore, self stigma is associated with lower empowerment (Ritsher et al. 2004), a poorer social network (Lysaker et al. 2007), lower compliance (Fung et al. 2008) and a higher extent of symptoms (Corrigan et al. 2006). The stigma of mental illness leads to an impaired pursuance of individual life goals, as job-related ambitions or living in a relationship (Rüesch 2005).

Current approaches targeting the stigma of mental illness primarily focus on education about mental illness in different target groups (e.g. Gaebel et al. 2003, 2004) and can be successful, if appropriately implemented (Gaebel et al. 2008). Yet there is a lack of RCT-tested psychotherapeutic approaches which directly address patients with mental illness improving their skills of coping with stigma and discrimination. Therefore it is intended to develop, manualise, and to evaluate such a psychotherapeutic group intervention within a randomized clinical control group design.

In this context, group-based cognitive-behavioral psychotherapy has been proved as efficient therapeutic approach for patients with depression (cf. McDermut et al. 2006) and with schizophrenia (cf. Lawrence et al. 2006, Barrowclough et al. 2006) in different settings. Patients can serve each other as role models and will modify negative self-related cognitions, thus developing new cognitions supporting self-esteem (Corrigan et al. 2001). The following interventional effects should improve the patients' quality of life and also result in a reduction of frequency and length of inpatient stays and sickness-related absenteeism:

  • improved skills to cope with negative stigmatizing experiences,
  • a reduced burden through of self-stigmatizing cognitions,
  • a better utilization of resources for disease managing in coherence with reduced self-stigmatization, and
  • an improved coping with stigma-related conflicts at work.
Interventional
 
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Schizophrenia
  • Depression
  • Behavioral: psychotherapeutic STEM modules
    psychoeducational and psychotherapeutical group intervention. 8 sessions of psychoeducation + 3 sessions + 1 booster session of STEM module for schizophrenia or depression)
  • Behavioral: Interventional control of normal psychoeducational treatment
    11 sessions + 1 booster session of psychoeducation (for schizophrenia or depression)
  • Experimental: Interventional: STEM modules
    8 sessions of psychoeducation + 3 sessions + 1 booster session of STEM module (for schizophrenia or depression)
    Intervention: Behavioral: psychotherapeutic STEM modules
  • Interventional Control
    11 sessions + 1 booster session of psychoeducation for schizophrenia or depression)
    Intervention: Behavioral: Interventional control of normal psychoeducational treatment

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
512
June 2014
March 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18 - 65 years
  • ICD-10 diagnosis of F2, F31.3-31.5, F32-34, F34.2, F43.2
  • patients who would participate in a psychoeducational group therapy in their regular treatment
  • written informed consent of the patient willing to participate
  • capacity of giving consent (as diagnosed by the investigator)

Exclusion Criteria:

  • insufficient knowledge of german language (reading, understanding and speaking not sufficient, as judged by the investigator)
  • acute psychotic or dissociative condition
Both
18 Years to 65 Years
No
Contact: Wolfgang Gaebel, Prof. Dr. 0049 211 922 20 00 wolfgang.gaebel@uni-duesseldorf.de
Contact: Stefanie Sauter 0049 211 922 277 4 stefanie.sauter@lvr.de
Germany
 
NCT01655368
STEM
No
Wolfgang Gaebel, Professor, Heinrich-Heine University, Duesseldorf
Wolfgang Gaebel, Professor
German Federal Ministry of Education and Research
 
Heinrich-Heine University, Duesseldorf
August 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP